Clinical Trial Update: Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing silodosin versus tamsulosin for stone clearance after extracorporeal shock wave lithotripsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Flomax (tamsulosin hydrochloride)
• Rapaflo (silodosin)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Kidney Stones | Phase 3 | Status: WITHDRAWN